As the pandemic continues in many countries across the world, people who use drugs face more marginalisation and stigma than ever before. With many resources re-directed to COVID-19, there are also significant challenges in accessing testing and treatment for hepatitis C and other infectious diseases.
It is for this reason that we believe the 2021 INHSU Conference is one of the most important we will hold to date.
After careful consideration and global consultation, we are delighted to announce that the 9th International Conference on Health and Hepatitis Care in Substance Users will take place in Australia, via a hybrid delivery model.
For those who can travel, we will be holding a face-to-face event in Sydney, Australia. For those who are unable to travel, we will be hosting conference sessions virtually, available both live and on-demand.
We hope you will join us for another year of knowledge exchange to ultimately help improve the health of people who use drugs.
Jason Grebely, INHSU President
The key deadlines for abstract submissions, scholarship and registrations are below.
Sign up for our mailing list for reminders.
- Abstract Submission: 25 April 2021
- Scholarship Applications: 25 April 2021
- Late Breaker Abstracts Open: 7 June 2021
- Late Breaker Abstracts Close: 4 July 2021
- Early Bird Registration: 25 July 2021
- Accommodation: 29 August 2021
- Standard Registration: 19 September 2021
New hybrid model – this year’s event will be a hybrid model with an in-person event in Sydney, Australia and live and on-demand streaming to provide access to people across the globe.
New health focus – in line with our new strategic direction and name, we will be broadening the focus to include not just HCV but also other infectious diseases and the broader health of people who use drugs.
The conference archives
Explore every paper that has been presented at INHSU’s international conference since 2015.
Download programs and handbooks from our past conferences.